Teriflunomide
NDC 69339-170, Teriflunomide, tablet, from Natco Pharma USA LLC.
- Product NDC
- 69339-170
- Status
- Listed
- Labeler
- Natco Pharma USA LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209555
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69339-170 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TERIFLUNOMIDE14 mg/1
Pharmacologic classes
Dihydroorotate Dehydrogenase Inhibitors [MoA]; Pyrimidine Synthesis Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69339-170-03 | 69339017003 | 30 TABLET in 1 BOTTLE (69339-170-03) |
| 69339-170-09 | 69339017009 | 90 TABLET in 1 BOTTLE (69339-170-09) |
| 69339-170-93 | 69339017093 | 2 BLISTER PACK in 1 CARTON (69339-170-93) / 30 TABLET in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/8219b4a2-fb9d-4387-ba33-96d28aad71dd
Use it
Look up 69339-170 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69339-170 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69339-170. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.